Virus-like nanoparticle vaccine used to guard against RSV

Researchers at Georgia State University say they created a new RSV vaccine from virus-like nanoparticles. The respiratory virus infects the lungs and breathing passageways. And this new approach worked in protecting mouse models for the disease. "Recombinant engineered nanoparticle vaccines might be developed to prevent highly contagious respiratory pathogens such as RSV, as reported in this study," said Dr. Sang-Moo Kang, a professor in the Institute for Biomedical Sciences at Georgia State. Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.